TABLE OF CONTENTS
Volume 31, Issue 6 (June 2006)
Perspectives
A Review and Update of Mechanisms of Estrogen in the Hippocampus and Amygdala for Anxiety and Depression Behavior FREE
Alicia A Walf and Cheryl A Frye
Neuropsychopharmacology 31: 1097-1111; advance online publication, March 22, 2006; doi:10.1038/sj.npp.1301067
Original Articles
Preclinical Research
Metabotropic Glutamate Receptor Subtype 7 Ablation Causes Dysregulation of the HPA Axis and Increases Hippocampal BDNF Protein Levels: Implications for Stress-Related Psychiatric Disorders FREE
Kayo Mitsukawa, Cedric Mombereau, Erika Lötscher, Doncho P Uzunov, Herman van der Putten, Peter J Flor and John F Cryan
Neuropsychopharmacology 31: 1112-1122; advance online publication, October 12, 2005; doi:10.1038/sj.npp.1300926
A Centrally Acting, Anxiolytic Angiotensin II AT1 Receptor Antagonist Prevents the Isolation Stress-Induced Decrease in Cortical CRF1 Receptor and Benzodiazepine Binding FREE
Juan M Saavedra, Ines Armando, Claudia Bregonzio, Augusto Juorio, Miroslava Macova, Jaroslav Pavel and Enrique Sanchez-Lemus
Neuropsychopharmacology 31: 1123-1134; advance online publication, October 5, 2005; doi:10.1038/sj.npp.1300921
Melanin-Concentrating Hormone-1 Receptor Modulates Neuroendocrine, Behavioral, and Corticolimbic Neurochemical Stress Responses in Mice FREE
Daniel G Smith, Richard J Davis, Linda Rorick-Kehn, Michelle Morin, Jeffrey M Witkin, David L McKinzie, George G Nomikos and Donald R Gehlert
Neuropsychopharmacology 31: 1135-1145; advance online publication, October 5, 2005; doi:10.1038/sj.npp.1300913
The Alpha2-Adrenoceptor Antagonist Dexefaroxan Enhances Hippocampal Neurogenesis by Increasing the Survival and Differentiation of New Granule Cells FREE
Pamela Rizk, Julio Salazar, Rita Raisman-Vozari, Marc Marien, Merle Ruberg, Francis Colpaert and Thomas Debeir
Neuropsychopharmacology 31: 1146-1157; advance online publication, November 16, 2005; doi:10.1038/sj.npp.1300954
Metabolite 1 of Protopanaxadiol-Type Saponins, an Axonal Regenerative Factor, Stimulates Teneurin-2 Linked by PI3-Kinase Cascade FREE
Chihiro Tohda, Itsuki Hashimoto, Tomoharu Kuboyama and Katsuko Komatsu
Neuropsychopharmacology 31: 1158-1164; advance online publication, November 2, 2005; doi:10.1038/sj.npp.1300943
Cell Proliferation is Influenced by Bulbectomy and Normalized by Imipramine Treatment in a Region-Specific Manner FREE
Gerburg Keilhoff, Axel Becker, Gisela Grecksch, Hans-Gert Bernstein and Gerald Wolf
Neuropsychopharmacology 31: 1165-1176; advance online publication, October 5, 2005; doi:10.1038/sj.npp.1300924
Limbic System Participates in Mediating the Effects of General Anesthetics FREE
Jingyi Ma and L Stan Leung
Neuropsychopharmacology 31: 1177-1192; advance online publication, October 5, 2005; doi:10.1038/sj.npp.1300909
Sex Differences in Neurochemical Effects of Dopaminergic Drugs in Rat Striatum FREE
Q David Walker, Rupa Ray and Cynthia M Kuhn
Neuropsychopharmacology 31: 1193-1202; advance online publication, October 12, 2005; doi:10.1038/sj.npp.1300915
Nicotine Self-Administration Acutely Activates Brain Reward Systems and Induces a Long-Lasting Increase in Reward Sensitivity FREE
Paul J Kenny and Athina Markou
Neuropsychopharmacology 31: 1203-1211; advance online publication, September 28, 2005; doi:10.1038/sj.npp.1300905
Changes in Accumbal and Pallidal pCREB and 
FosB in Morphine-Sensitized Rats: Correlations with Receptor-Evoked Electrophysiological Measures in the Ventral Pallidum FREE
John McDaid, Jeanine E Dallimore, Alexander R Mackie and T Celeste Napier
Neuropsychopharmacology 31: 1212-1226; advance online publication, August 10, 2005; doi:10.1038/sj.npp.1300854
Microinjection of Naltrexone into the Central, but not the Basolateral, Amygdala Blocks the Anxiolytic Effects of Diazepam in the Plus Maze FREE
Paul R Burghardt and Marlene A Wilson
Neuropsychopharmacology 31: 1227-1240; advance online publication, August 10, 2005; doi:10.1038/sj.npp.1300864
Social Defeat Stress-Induced Behavioral Responses are Mediated by the Endogenous Kappa Opioid System FREE
Jay P McLaughlin, Shuang Li, Joseph Valdez, Theodore A Chavkin and Charles Chavkin
Neuropsychopharmacology 31: 1241-1248; advance online publication, August 17, 2005; doi:10.1038/sj.npp.1300872
Clinical Research
Neuroactive Steroids are Altered in Schizophrenia and Bipolar Disorder: Relevance to Pathophysiology and Therapeutics FREE
Christine E Marx, Robert D Stevens, Lawrence J Shampine, Veska Uzunova, William T Trost, Marian I Butterfield, Mark W Massing, Robert M Hamer, A Leslie Morrow and Jeffrey A Lieberman
Neuropsychopharmacology 31: 1249-1263; advance online publication, November 23, 2005; doi:10.1038/sj.npp.1300952
Neurochemical Effects of Olanzapine in First-Hospitalization Manic Adolescents: A Proton Magnetic Resonance Spectroscopy Study FREE
Melissa P DelBello, Kim M Cecil, Caleb M Adler, John P Daniels and Stephen M Strakowski
Neuropsychopharmacology 31: 1264-1273; advance online publication, November 2, 2005; doi:10.1038/sj.npp.1300950
Multiple Dose Pharmacokinetics of Paroxetine in Children and Adolescents with Major Depressive Disorder or Obsessive–Compulsive Disorder FREE
Robert L Findling, Gianluca Nucci, Antoni A Piergies, Roberto Gomeni, Edward I Bartolic, Regan Fong, David J Carpenter, J Steven Leeder, Andrea Gaedigk and Theodore M Danoff
Neuropsychopharmacology 31: 1274-1285; advance online publication, November 23, 2005; doi:10.1038/sj.npp.1300960
Alteration of Decreased Plasma NO Metabolites and Platelet NO Synthase Activity by Paroxetine in Depressed Patients FREE
Wendy Chrapko, Paul Jurasz, Marek W Radomski, Stephen L Archer, Stephen C Newman, Glen Baker, Nathalie Lara and Jean-Michel Le Mellédo
Neuropsychopharmacology 31: 1286-1293; advance online publication, November 23, 2005; doi:10.1038/sj.npp.1300961
Differential Effects of the Muscarinic M1 Receptor Agonist RS-86 and the Acetylcholine-Esterase Inhibitor Donepezil on REM Sleep Regulation in Healthy Volunteers FREE
Christoph Nissen, Eric A Nofzinger, Bernd Feige, Bernhard Waldheim, Marc-Philipp Radosa, Dieter Riemann and Mathias Berger
Neuropsychopharmacology 31: 1294-1300; advance online publication, September 28, 2005; doi:10.1038/sj.npp.1300906
Neuropsychological Profile of Acute Alcohol Intoxication during Ascending and Descending Blood Alcohol Concentrations FREE
Tom A Schweizer, Muriel Vogel-Sprott, James Danckert, Eric A Roy, Amanda Skakum and Carole E Broderick
Neuropsychopharmacology 31: 1301-1309; advance online publication, October 26, 2005; doi:10.1038/sj.npp.1300941
The Effect of Olanzapine on Craving and Alcohol Consumption FREE
Kent E Hutchison, Lara Ray, Erica Sandman, Marie-Christine Rutter, Annie Peters, Dena Davidson and Robert Swift
Neuropsychopharmacology 31: 1310-1317; advance online publication, October 12, 2005; doi:10.1038/sj.npp.1300917
Cerebellar Vermis Involvement in Cocaine-Related Behaviors FREE
Carl M Anderson, Luis C Maas, Blaise deB Frederick, Jacob T Bendor, Thomas J Spencer, Eli Livni, Scott E Lukas, Alan J Fischman, Bertha K Madras, Perry F Renshaw and Marc J Kaufman
Neuropsychopharmacology 31: 1318-1326; advance online publication, October 12, 2005; doi:10.1038/sj.npp.1300937
PET Network Abnormalities and Cognitive Decline in Patients with Mild Cognitive Impairment FREE
Davangere P Devanand, Christian G Habeck, Matthias H Tabert, Nikolaos Scarmeas, Gregory H Pelton, James R Moeller, Brett D Mensh, Tyler Tarabula, Ronald L Van Heertum and Yaakov Stern
Neuropsychopharmacology 31: 1327-1334; advance online publication, November 9, 2005; doi:10.1038/sj.npp.1300942
A Ser9Gly Polymorphism in the Dopamine D3 Receptor Gene (DRD3) and Event-Related P300 Potentials FREE
Christoph Mulert, Georg Juckel, Ina Giegling, Oliver Pogarell, Gregor Leicht, Susanne Karch, Paraskevi Mavrogiorgou, Hans-Jürgen Möller, Ulrich Hegerl and Dan Rujescu
Neuropsychopharmacology 31: 1335-1344; advance online publication, January 4, 2006; doi:10.1038/sj.npp.1300984
